Rocket Pharmaceuticals Inc (NASDAQ: RCKT) on Tuesday, plunged -5.56% from the previous trading day, before settling in for the closing price of $2.88. Within the past 52 weeks, RCKT’s price has moved between $2.19 and $26.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 18.96%. With a float of $99.77 million, this company’s outstanding shares have now reached $106.75 million.
The extent of productivity of a business whose workforce counts for 299 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Rocket Pharmaceuticals Inc (RCKT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rocket Pharmaceuticals Inc is 7.39%, while institutional ownership is 87.14%. The most recent insider transaction that took place on May 20 ’25, was worth 2,301. In this transaction an insider of this company sold 357 shares at a rate of $6.45, taking the stock ownership to the 64,027 shares. Before that another transaction happened on May 20 ’25, when Company’s insider sold 801 for $6.45, making the entire transaction worth $5,163. This insider now owns 235,255 shares in total.
Rocket Pharmaceuticals Inc (RCKT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 18.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.20% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Rocket Pharmaceuticals Inc (RCKT) is currently performing well based on its current performance indicators. A quick ratio of 9.19 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.63, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
The latest stats from [Rocket Pharmaceuticals Inc, RCKT] show that its last 5-days average volume of 3.82 million was superior to 3.36 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 21.03%. Additionally, its Average True Range was 0.47.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 5.72%, which indicates a significant decrease from 34.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.35% in the past 14 days, which was lower than the 180.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.40, while its 200-day Moving Average is $11.35. Now, the first resistance to watch is $2.89. This is followed by the second major resistance level at $3.05. The third major resistance level sits at $3.15. If the price goes on to break the first support level at $2.63, it is likely to go to the next support level at $2.53. Assuming the price breaks the second support level, the third support level stands at $2.37.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
Market capitalization of the company is 293.05 million based on 106,786K outstanding shares. Right now, sales total 0 K and income totals -258,750 K. The company made 0 K in profit during its latest quarter, and -61,330 K in sales during its previous quarter.
